Laurent Kaiser

Active 1996–2025

230
Papers
23,289
Citations
86
h-index
222
i10-index

Citations

Citations per year for Laurent Kaiser1933: 1 citations1959: 1 citations1994: 1 citations1995: 1 citations1997: 5 citations1998: 9 citations1999: 8 citations2000: 35 citations2001: 60 citations2002: 77 citations2003: 78 citations2004: 94 citations2005: 98 citations2006: 105 citations2007: 93 citations2008: 120 citations2009: 116 citations2010: 107 citations2011: 119 citations2012: 97 citations2013: 113 citations2014: 90 citations2015: 97 citations2016: 127 citations2017: 136 citations2018: 112 citations2019: 424 citations2020: 1,059 citations2021: 1,412 citations2022: 911 citations2023: 498 citations2024: 683 citations2025: 300 citations2026: 11 citations1934–1958: no citations, so these years are not shown1960–1993: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,426 citing papers, 21.4% of this breakdownUnited Kingdom: 909 citing papers, 8% of this breakdownSwitzerland: 697 citing papers, 6.1% of this breakdownChina: 584 citing papers, 5.1% of this breakdownGermany: 486 citing papers, 4.3% of this breakdownFrance: 453 citing papers, 4% of this breakdownCanada: 438 citing papers, 3.9% of this breakdownItaly: 403 citing papers, 3.6% of this breakdownAustralia: 313 citing papers, 2.8% of this breakdownSpain: 294 citing papers, 2.6% of this breakdownNetherlands: 290 citing papers, 2.6% of this breakdownIndia: 226 citing papers, 2% of this breakdown
0%21.4%Other 33.6%

Fields

  • Medicine75.7%
  • Immunology and Microbiology8.7%
  • Biochemistry, Genetics and Molecular Biology4.3%
  • Mathematics3.4%
  • Engineering1.2%
  • Agricultural and Biological Sciences1.2%
  • Other5.5%

Topics

  • SARS-CoV-2 and COVID-19 Research8.9%
  • COVID-19 Clinical Research Studies6%
  • Respiratory viral infections research5.3%
  • SARS-CoV-2 detection and testing4.2%
  • Influenza Virus Research Studies3.1%
  • COVID-19 epidemiological studies2.9%
  • Other69.6%

Coauthors

All papers

Open in search
  1. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2

    Authors: , , , , , , , , , , - Nature Medicine 2022 cited by 374

  2. Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia

    Authors: , , , , , , , , , , , , , , , - JAMA 2020 cited by 251

  3. Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study

    Authors: , , , , , , , , , , , - BMC Infectious Diseases 2018 cited by 117

  4. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Materials 2017 cited by 426

  5. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enos Bernasconi, Dominique L. Braun, H C Bucher, Alexandra Calmy, Matthias Cavassini, Angela Ciuffi, G Dollenmaier, Matthias Egger, Luigia Elzi, Jan Fehr, Jacques Fellay, Hansjakob Furrer, C A Fux, Huldrych F. Günthard, Anna Hachfeld, D Haerry, Barbara Hasse, Hans H. Hirsch, Matthias Hoffmann, Irène Hösli, M Huber, David Jackson‐Perry, C R Kahlert, Laurent Kaiser, Olivia Keiser, Thomas Klimkait, Roger D. Kouyos, Helen Kovari, Katharina Kusejko, Niklaus Daniel Labhardt, Karoline Leuzinger, Begoña Martínez de Tejada, Catia Marzolini, Karin J. Metzner, Nora Müller, Johannes Nemeth, Dunja Nicca, Julia Notter, P Paioni, G Pantaleo, Matthieu Perreau, Andri Rauch, Luisa Salazar‐Vizcaya, Patrick Schmid, Roberto F. Speck, M Stöckle, Philip Tarr, Alexandra Trkola, Gilles Wandeler, Maja Weisser, Sabine Yerly - The Lancet Regional Health - Europe 2023 cited by 51

  6. Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jürg Böni, Dominique L. Braun, Heiner C. Bucher, Alexandra Calmy, Matthias Cavassini, Angela Ciuffi, G Dollenmaier, Matthias Egger, Luigia Elzi, Jan Fehr, Jacques Fellay, Hansjakob Furrer, Christoph A. Fux, Huldrych F. Günthard, David Haerry, Barbara Hasse, Hans H. Hirsch, Matthias Hoffmann, Irène Hösli, Michael Huber, Christian R. Kahlert, Laurent Kaiser, Olivia Keiser, Thomas Klimkait, Roger D. Kouyos, Helen Kovari, Bruno Ledergerber, G Martinetti, Begoña Martínez de Tejada, Catia Marzolini, Karin J. Metzner, N Müller, Dunja Nicca, P Paioni, Guiseppe Pantaleo, Matthieu Perreau, Andri Rauch, Christoph Rudin, Alexandra Scherrer, Patrick Schmid, Roberto F. Speck, M Stöckle, Philip Tarr, Alexandra Trkola, Pietro Vernazza, Gilles Wandeler, Rainer Weber, Sabine Yerly - Nature Communications 2019 cited by 190

  7. Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Battegay, Enos Bernasconi, Jürg Böni, Dominique L. Braun, Heiner C. Bucher, Alexandra Calmy, Matthias Cavassini, Angela Ciuffi, G Dollenmaier, Matthias Egger, Luigia Elzi, Jan Fehr, Jacques Fellay, Hansjakob Furrer, C A Fux, Huldrych F. Günthard, David Haerry, Barbara Hasse, Hans H. Hirsch, Marc Hoffmann, Irène Hösli, Michael Huber, Christian R. Kahlert, Laurent Kaiser, Olivia Keiser, Thomas Klimkait, Roger D. Kouyos, Helen Kovari, Bruno Ledergerber, G Martinetti, Begoña Martínez de Tejada, Catia Marzolini, Karin J. Metzner, N Müller, Dunja Nicca, P Paioni, G Pantaleo, Matthieu Perreau, Andri Rauch, Charles M. Rudin, Alexandra Scherrer, Patrick Schmid, René Speck, M Stöckle, Philip Tarr, Alexandra Trkola, Pietro Vernazza, Gilles Wandeler, Rainer Weber, Sabine Yerly - International Journal of Epidemiology 2021 cited by 144

  8. Characteristics of long-COVID among older adults: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - International Journal of Infectious Diseases 2022 cited by 80

  9. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract

    Authors: , , , , , , , - Emerging Microbes & Infections 2021 cited by 62

  10. Picornavirus and enterovirus diversity with associated human diseases

    Authors: , , , - Infection Genetics and Evolution 2012 cited by 445

  11. Interferon-Dependent and Respiratory Virus-Specific Interference in Dual Infections of Airway Epithelia

    Authors: , , , , , - Scientific Reports 2020 cited by 75

  12. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Egger, Luisa Elzi, Jan Fehr, Jacques Fellay, Hansjakob Furrer, Christoph A. Fux, Huldrych F. Günthard, Anna Hachfeld, D Haerry, Barbara Hasse, Hans H. Hirsch, Matthias Hoffmann, Irène Hösli, Michael Huber, David Jackson‐Perry, Christian R. Kahlert, Laurent Kaiser, Olivia Keiser, Thomas Klimkait, Roger D. Kouyos, Helen Kovari, Katharina Kusejko, Niklaus Daniel Labhardt, Karoline Leuzinger, Begogna Martinez de Tejada, Catja Marzolini, Karin J. Metzner, Nicolas Müller, Johannes Nemeth, Dunja Nicca, Julia Notter, P Paioni, Giuseppe Pantaleo, Matthieu Perreau, Andri Rauch, Luisa Salazar‐Vizcaya, Patrick Schmid, Roberto F. Speck, M Stöckle, Philip Tarr, Alexandra Trkola, Gilles Wandeler, Maja Weisser, Sabine Yerly - The Journal of Experimental Medicine 2024 cited by 38

  13. Influenza virus neuraminidase inhibitors

    Authors: , , - The Lancet 2000 cited by 736

  14. Severe viral respiratory infections in children with IFIH1 loss-of-function mutations

    Authors: , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 160

  15. Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study

    Authors: , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2018 cited by 99

  16. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 94

  17. The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge

    Authors: , , , , , - Journal of Allergy and Clinical Immunology 2010 cited by 345

  18. Outbreak analytics: a developing data science for informing the response to emerging pathogens

    Authors: , , , , , , , , , , , , , , , , , , - Philosophical Transactions of the Royal Society B Biological Sciences 2019 cited by 186

  19. RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions

    Authors: , , , , , , - Viruses 2021 cited by 55

  20. Influenza A virus exploits transferrin receptor recycling to enter host cells

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 54

  21. The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Agoritsas, Marwène Grira, José Luís Sandoval, Julien Ehrsam, Simon Regard, Camille Genecand, Aglaé Tardin, Laurent Kaiser, François Chappuis, Idris Guessous, Idris Guessous - Scientific Reports 2022 cited by 52

  22. Modified cyclodextrins as broad-spectrum antivirals

    Authors: , , , , , , , , , , , , , , , , , - Science Advances 2020 cited by 190

  23. Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures

    Authors: , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2017 cited by 135

  24. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

    Authors: , , , , , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 93